These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35295979)

  • 1. Lack of direct association between oral mucosal lesions and SARS-CoV- 2 in a cohort of patients hospitalised with COVID-19.
    Schwab G; Palmieri M; Zerbinati RM; Sarmento DJS; Reis T; Ortega KL; Kano IT; Caixeta RAV; Hasséus B; Sapkota D; Junges R; Giannecchini S; Costa ALF; Jales SMCP; Lindoso JAL; Gallo CB; Braz-Silva PH
    J Oral Microbiol; 2022; 14(1):2047491. PubMed ID: 35295979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral mucosal lesions and oral symptoms of the SARS-CoV-2 infection.
    Surboyo MD; Ernawati DS; Budi HS
    Minerva Dent Oral Sci; 2021 Aug; 70(4):161-168. PubMed ID: 34269548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Manifestation of SARS-CoV-2 infection on oral mouth mucosa].
    Laskowska E; Radwan-Oczko M
    Pol Merkur Lekarski; 2021 Oct; 49(293):374-378. PubMed ID: 34800028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 manifestation in the oral cavity - a narrative literature review.
    Kusiak A; Cichońska D; Tubaja M; Skorek A; Jereczek-Fossa BA; Corrao G; Marvaso G; Alterio D
    Acta Otorhinolaryngol Ital; 2021 Oct; 41(5):395-400. PubMed ID: 34734574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The spectrum of non-characteristic oral manifestations in COVID-19 - a scoping brief commentary.
    Hüpsch-Marzec H; Dziedzic A; Skaba D; Tanasiewicz M
    Med Pr; 2021 Dec; 72(6):685-692. PubMed ID: 34596170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Viral Infections With Oral Cavity Lesions: Role of SARS-CoV-2 Infection.
    La Rosa GRM; Libra M; De Pasquale R; Ferlito S; Pedullà E
    Front Med (Lausanne); 2020; 7():571214. PubMed ID: 33521007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral mucosal lesions in patients with COVID-19: a systematic review.
    Bhujel N; Zaheer K; Singh RP
    Br J Oral Maxillofac Surg; 2021 Nov; 59(9):1024-1030. PubMed ID: 34563354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Pathology in COVID-19 and SARS-CoV-2 Infection-Molecular Aspects.
    Drozdzik A; Drozdzik M
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is SARS-CoV-2 an Etiologic Agent or Predisposing Factor for Oral Lesions in COVID-19 Patients? A Concise Review of Reported Cases in the Literature.
    Etemad-Moghadam S; Alaeddini M
    Int J Dent; 2021; 2021():6648082. PubMed ID: 34054961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the viral loads of SARS-CoV-2 in the oral cavity when complicated with periapical lesions.
    Altaie AM; Hamdy R; Venkatachalam T; Hamoudi R; Soliman SSM
    BMC Oral Health; 2021 Nov; 21(1):567. PubMed ID: 34749700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral lesions in patients with SARS-CoV-2 infection: could the oral cavity be a target organ?
    Brandão TB; Gueiros LA; Melo TS; Prado-Ribeiro AC; Nesrallah ACFA; Prado GVB; Santos-Silva AR; Migliorati CA
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Feb; 131(2):e45-e51. PubMed ID: 32888876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Infection and Significance of Oral Health Management in the Era of "the New Normal with COVID-19".
    Imai K; Tanaka H
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent and Persistent Salivary Gland Ectasia and Oral Disease After COVID-19.
    Gherlone EF; Polizzi E; Tetè G; De Lorenzo R; Magnaghi C; Rovere Querini P; Ciceri F
    J Dent Res; 2021 May; 100(5):464-471. PubMed ID: 33655804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age and gender differences in ACE2 and TMPRSS2 expressions in oral epithelial cells.
    Peng J; Sun J; Zhao J; Deng X; Guo F; Chen L
    J Transl Med; 2021 Aug; 19(1):358. PubMed ID: 34412632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Oral Lesions in COVID-19 Egyptian Patients.
    Elamrousy WAH; Nassar M; Issa DR
    J Int Soc Prev Community Dent; 2021; 11(6):712-720. PubMed ID: 35036381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and the Risk of SARS-CoV-2 Infection or Hospitalization With COVID-19 Disease: A Systematic Review and Meta-Analysis.
    Tleyjeh IM; Bin Abdulhak AA; Tlayjeh H; Al-Mallah MH; Sohail MR; Hassett LC; Siller-Matula JM; Kashour T
    Am J Ther; 2020 Dec; 29(1):e74-e84. PubMed ID: 33395057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of oral ulcerative lesions in COVID-19 patients: A comprehensive study of 51 cases.
    Wu YH; Wu YC; Lang MJ; Lee YP; Jin YT; Chiang CP
    J Dent Sci; 2021 Oct; 16(4):1066-1073. PubMed ID: 34306539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral lesions associated with COVID-19: A systematic review.
    Uzêda-E-Silva VD; de Sá IB; Martins J; Pedreira N; Vieira VPS; Silva BHM
    Stomatologija; 2021; 23(1):3-8. PubMed ID: 34528901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 and Its Repercussions on Oral Health: A Review.
    Rusu LC; Ardelean LC; Tigmeanu CV; Matichescu A; Sauciur I; Bratu EA
    Medicina (Kaunas); 2021 Nov; 57(11):. PubMed ID: 34833407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge.
    Zuo T; Zhan H; Zhang F; Liu Q; Tso EYK; Lui GCY; Chen N; Li A; Lu W; Chan FKL; Chan PKS; Ng SC
    Gastroenterology; 2020 Oct; 159(4):1302-1310.e5. PubMed ID: 32598884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.